MannKind (FRA:NNFN) Beginning Cash Position : €219.4 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is MannKind Beginning Cash Position?

MannKind's Beginning Cash Position for the quarter that ended in Mar. 2024 was €219.4 Mil.

MannKind's quarterly Beginning Cash Position declined from Sep. 2023 (€80.8 Mil) to Dec. 2023 (€76.1 Mil) but then increased from Dec. 2023 (€76.1 Mil) to Mar. 2024 (€219.4 Mil).

MannKind's annual Beginning Cash Position increased from Dec. 2021 (€59.4 Mil) to Dec. 2022 (€117.2 Mil) but then declined from Dec. 2022 (€117.2 Mil) to Dec. 2023 (€64.0 Mil).

MannKind Beginning Cash Position Historical Data

The historical data trend for MannKind's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Beginning Cash Position Chart

MannKind Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

64.52

24.84

59.44

117.23

63.98

MannKind Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															65.16	79.26	80.75	76.13	219.40

MannKind Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

MannKind Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of MannKind's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

MannKind (FRA:NNFN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (FRA:NNFN) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

MNKD:USA

Address

1 Casper Street, Danbury, CT, USA, 06810

Website

https://www.mannkindcorp.com

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind (FRA:NNFN) Headlines

No Headlines